Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

8.865
+0.1551.78%
Volume:95.91M
Turnover:839.32M
Market Cap:102.14B
PE:22.32
High:8.890
Open:8.580
Low:8.520
Close:8.710
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.83
T/O Rate:0.83%
Dividend:0.34
Dividend Rate:3.80%
EPS(LYR):0.397
ROE:20.90%
ROA:10.70%
PB:2.32
PE(LYR):22.32
PS:2.79

Loading ...

Movement Alert|CSPC PHARMA Rises 3.13% in Regular Trading, RSV Vaccine Receives FDA Clinical Trial Approval While Multiple Banks Raise Target Prices

Market Focus
·
Aug 26

CSPC Pharma secures U.S. FDA clearance for Phase I trial of second recombinant RSV vaccine SYS6057

Bulletin Express
·
Aug 25

CSPC Pharma's Recombinant RSV Vaccine Wins US Clinical Trial Clearance

Stock News
·
Aug 25

CSPC Says FDA Clears RSV Vaccine Candidate SYS 6057 for US Clinical Trial

Reuters
·
Aug 25

CSPC Pharmaceutical - Recombinant Respiratory Syncytial Virus Vaccine (Sys6057) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
Aug 25

CSPC Pharmaceutical - Sys6057 Receives Nmpa Approval on July 30, 2026 to Conduct Clinical Trials in China

THOMSON REUTERS
·
Aug 25

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.93 From HK$10.31, Keeps at Buy

MT Newswires Live
·
Aug 24

CSPC Pharmaceutical Group Stock Climbs 2.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 24

Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results

Stock News
·
Aug 24

Movement Alert|CSPC PHARMA Rises 4.46% in Regular Trading, Multiple Investment Banks Raise Target Prices Post-Earnings

Market Focus
·
Aug 24

BofA Securities Lifts CSPC Pharma Target Price to HK$8.6 While Maintaining Underperform Rating

Deep News
·
Aug 23

UBS Lifts CSPC Pharma Price Target to HK$11.80, Reiterates Buy Rating

Deep News
·
Aug 23

Goldman Sachs Adjusts CSPC Pharma Target Price Upward While Retaining Buy Stance

Deep News
·
Aug 23

CSPC Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
Aug 23

China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution

Reuters
·
Aug 21

UOB Kay Hian Upgrades CSPC Pharmaceutical Group to Buy from Sell; Price Target is HK$11.50

MT Newswires Live
·
Aug 21

Goldman Sachs Raises CSPC Pharma Price Target to HK$12.56, Reaffirms Buy Rating

Stock News
·
Aug 21

CSPC Pharmaceutical Group Stock Falls 3.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 21

美银证券上调石药集团目标价至8.6港元,维持“跑输大市”评级

Stock News
·
Aug 21

Morgan Stanley Raises CSPC Pharma Target Price to HK$12, Maintains Overweight Rating

Stock News
·
Aug 21